Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...
Results from a phase 1 study showed TEV-53408 reduced free serum IL-15 levels in healthy participants. The Food and Drug Administration (FDA) has granted Fast Track designation to TEV-53408, an ...
Some immune cells in our bodies see their “killer instinct” restricted after entering solid tumors, according to new research. Now, researchers from the University of Birmingham and the University of ...
Circulating epithelial tumor cells (CETC) during preoperative chemotherapy (CTX) of patients with gastric cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results